Keybanc Maintains Overweight on Progyny, Raises Price Target to $35

Benzinga Newsdesk www.benzinga.com Positive 70.3%

Neg 0% Neu 0% Pos 70.3%

Keybanc analyst Scott Schoenhaus maintains Progyny (NASDAQ:PGNY) with a Overweight and raises the price target from $30 to $35.